Safety Risk Communication for Medical Products

In this virtual training course, learn how to enhance the effectiveness of safety risk communication in light of evolving regulatory expectations.

Back to Agenda

Session 10: Who’s Responsible for Communicating Drug Safety Information?

Session Chair(s)

Meredith Smith, PhD, MPA, FISPE

Senior Director, Implementation Science Pillar Lead

Evidera, Inc, United States

This session will examine the role of regulatory authorities, pharmaceutical companies, and healthcare professionals in drug safety communication and will include an introduction to drug product labeling and drug advertising regulations in the US.